Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

SHE:002275 Revenue

Guilin Sanjin Pharmaceutical had revenue of 525.12M CNY in the quarter ending March 31, 2026, with 12.55% growth. This brings the company's revenue in the last twelve months to 2.10B, down -3.38% year-over-year. In the year 2025, Guilin Sanjin Pharmaceutical had annual revenue of 2.05B, down -6.76%.

• Revenue (ttm): 2.10B
• Revenue Growth: -3.38%
• P/S Ratio: 3.69
• Revenue / Employee: 823.27K
• Employees: 2,556
• Market Cap: 7.77B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.05B	-148.26M	-6.76%
Dec 31, 2024	2.19B	22.39M	1.03%
Dec 31, 2023	2.17B	211.87M	10.81%
Jan 1, 2023	1.96B	218.51M	12.55%
Jan 1, 2022	1.74B	174.74M	11.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 26, 2026

Data Sources Report a data error